Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04745962 · ClinicalTrials.gov registry record
Thin EBUS Pilot Study
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 51
- Enrollment target
NCT04745962: Completed study, sponsored by Medical University of South Carolina.
NCT04745962 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04745962 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This is a single-center pilot study at the Medical University of South Carolina (MUSC) to evaluate the safety and efficacy of the TCP-EBUS scope (Thin EBUS). This study will consist of a standard of care bronchoscopy and will be followed for approximately 3 months. While the device is not FDA approved, it is the same technology but a thinner version of the SCP-EBUS bronchoscope.
Primary Outcome
Study team will determine whether or not the lung nodule was able to be visualized by the scope.
Interventions
- DEVICE Slimscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2024-09-28 |
What the finished NCT04745962 record still lists
NCT04745962 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Slimscope is the first listed.
NCT04745962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04745962 about?
NCT04745962 is a clinical study titled "Thin EBUS Pilot Study". This is a single-center pilot study at the Medical University of South Carolina (MUSC) to evaluate the safety and efficacy of the TCP-EBUS scope (Thin EBUS). This study will consist of a standard of care bronchoscopy and will be followed for approximately 3 months. While the device is not FDA approv...
What is the current status of trial NCT04745962?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2020-09-09. Estimated completion is 2024-09-28.
What interventions are being tested in trial NCT04745962?
The interventions under investigation include: Slimscope (DEVICE).
Who is sponsoring clinical trial NCT04745962?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI